Navigation Links
Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
Date:5/28/2008

ROCKVILLE, Md., May 28 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the FBR Capital Markets 12th Annual Spring Investor Conference at 9:45 am. on May 29, 2008 at The Grand Hyatt Hotel in New York. Dr. Singhvi will provide an overview of the company's strategy, research and development progress. A link to the live presentation can be accessed via the Company website at http://www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.

ABOUT NOVAVAX

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary viruslike particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing a new, efficient manufacturing solution. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
2. Novavax Reports First Quarter 2008 Financial Results
3. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
4. Novavax Opens Its First U.S. Vaccine Plant
5. Novavax CEO to Present at the World Vaccine Congress 2008
6. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
7. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
8. Novavax CEO to Present at BIO CEO & Investor Conference
9. NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update
10. Abbott to Present at Goldman Sachs Global Healthcare Conference
11. 3SBio Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... ... April 20, 2017 , ... NetDimensions appoints Bill Mastin, a learning technology veteran, ... of experience in the learning technologies industry, Mastin joins NetDimensions from the New York ... plc (LTG). At LEO, Mastin served as SVP of the North America offices and ...
(Date:4/20/2017)... (PRWEB) , ... April 20, 2017 , ... ... formation of a unique intellectual property (IP) sharing and commercialization model. , The ... promising inventions. A main component of this effort is bringing the IP to ...
(Date:4/19/2017)... ... ... The Vibrating Orifice Aerosol Generator (VOAG) was developed in ... known diameters for research applications such as for calibrating droplet measuring instruments, for ... , The VOAG requires forcing liquid out of an orifice about half ...
(Date:4/19/2017)... , ... April 19, 2017 , ... Nobilis Therapeutics ... , Company Seeks to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder ... of an 81 patient clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic ...
Breaking Biology Technology:
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
Breaking Biology News(10 mins):